These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 32586733)
1. Ketoconazole-loaded poly-(lactic acid) nanoparticles: Characterization and improvement of antifungal efficacy in vitro against Candida and dermatophytes. Endo EH; Makimori RY; Companhoni MVP; Ueda-Nakamura T; Nakamura CV; Dias Filho BP J Mycol Med; 2020 Sep; 30(3):101003. PubMed ID: 32586733 [TBL] [Abstract][Full Text] [Related]
2. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans. de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951 [TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Gupta AK; Kohli Y Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235 [TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes. Shams-Ghahfarokhi M; Shokoohamiri MR; Amirrajab N; Moghadasi B; Ghajari A; Zeini F; Sadeghi G; Razzaghi-Abyaneh M Fitoterapia; 2006 Jun; 77(4):321-3. PubMed ID: 16690223 [TBL] [Abstract][Full Text] [Related]
5. In vitro antifungal activity of Polyporaceae against yeasts and dermatophytes. Steinmetz MD; Rascol JP; Régli P; Gargadennec A; Andary C Mycoses; 1995; 38(7-8):305-9. PubMed ID: 8559195 [TBL] [Abstract][Full Text] [Related]
6. Antifungal activities of different extracts of marine macroalgae against dermatophytes and Candida species. Guedes EA; Araújo MA; Souza AK; de Souza LI; de Barros LD; Maranhão FC; Sant'Ana AE Mycopathologia; 2012 Sep; 174(3):223-32. PubMed ID: 22528741 [TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes. Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461 [TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles containing copaiba oil and allantoin: development and role of nanoencapsulation on the antifungal activity. Svetlichny G; Külkamp-Guerreiro IC; Cunha SL; Silva FE; Bueno K; Pohlmann AR; Fuentefria AM; Guterres SS Pharmazie; 2015 Mar; 70(3):155-64. PubMed ID: 25980176 [TBL] [Abstract][Full Text] [Related]
9. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections. Dudhipala N; Ay AA Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084 [TBL] [Abstract][Full Text] [Related]
10. Enhanced effect in combination of curcumin- and ketoconazole-loaded methoxy poly (ethylene glycol)-poly (ε-caprolactone) micelles. Teng F; Deng P; Song Z; Zhou F; Feng R Biomed Pharmacother; 2017 Apr; 88():43-51. PubMed ID: 28092844 [TBL] [Abstract][Full Text] [Related]
11. Improved yeast delivery of fluconazole with a nanostructured lipid carrier system. Kelidari HR; Moazeni M; Babaei R; Saeedi M; Akbari J; Parkoohi PI; Nabili M; Gohar AA; Morteza-Semnani K; Nokhodchi A Biomed Pharmacother; 2017 May; 89():83-88. PubMed ID: 28222399 [TBL] [Abstract][Full Text] [Related]
12. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis. Jafri H; Ahmad I J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964 [TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens. Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm. Randhawa MA; Gondal MA; Al-Zahrani AH; Rashid SG; Ali A J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(2):119-24. PubMed ID: 25560257 [TBL] [Abstract][Full Text] [Related]
15. [Antifungal resistance: an emerging problem in Mexico]. Manzano-Gayosso P; Méndez-Tovar LJ; Hernández-Hernández F; López-Martínez R Gac Med Mex; 2008; 144(1):23-6. PubMed ID: 18619054 [TBL] [Abstract][Full Text] [Related]
16. Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. Moazeni M; Kelidari HR; Saeedi M; Morteza-Semnani K; Nabili M; Gohar AA; Akbari J; Lotfali E; Nokhodchi A Colloids Surf B Biointerfaces; 2016 Jun; 142():400-407. PubMed ID: 26974361 [TBL] [Abstract][Full Text] [Related]
17. [In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses]. Yamaguchi H; Ikeda F; Iyoda T; Suzuki M; Mikawa T Med Mycol J; 2014; 55(4):J157-63. PubMed ID: 25742996 [TBL] [Abstract][Full Text] [Related]
18. NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans. Pannu J; McCarthy A; Martin A; Hamouda T; Ciotti S; Fothergill A; Sutcliffe J Antimicrob Agents Chemother; 2009 Aug; 53(8):3273-9. PubMed ID: 19433562 [TBL] [Abstract][Full Text] [Related]
19. Anti-dermatophyte activity of Leguminosae plants from Southern Brazil with emphasis on Mimosa pigra (Leguminosae). de Morais CB; Scopel M; Pedrazza GPR; da Silva FK; Dalla Lana DF; Tonello ML; Miotto STS; Machado MM; De Oliveira LFS; Fuentefria AM; Zuanazzi JAS J Mycol Med; 2017 Dec; 27(4):530-538. PubMed ID: 28822705 [TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis. Mallié M; Montès B; Lebecq JC; Bastide JM Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]